View in EDS

Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia.
Authors: Dovey OM; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Cooper JL; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Mupo A; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Grove CS; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Australia.; PathWest Division of Clinical Pathology, Queen Elizabeth II Medical Centre, Nedlands, Australia., Lynn C; Leukemia and Stem Cell Biology Group, Division of Cancer Studies, Department of Haematological Medicine, King's College London, London, United Kingdom., Conte N; Sample Phenotype Ontology Team, European Bioinformatics Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Andrews RM; Institute of Translation, Innovation, Methodology, and Engagement, Cardiff University School of Medicine, Cardiff, United Kingdom., Pacharne S; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Tzelepis K; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Vijayabaskar MS; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Green P; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Rad R; Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.; German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany., Arends M; Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom., Wright P; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom; and., Yusa K; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Bradley A; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Varela I; Instituto de Biomedicina y Biotecnología de Cantabria, Santander, Spain., Vassiliou GS; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom; and.
Source: Blood [Blood] 2017 Oct 26; Vol. 130 (17), pp. 1911-1922. Date of Electronic Publication: 2017 Aug 23.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28835438
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dovey+OM%22">Dovey OM</searchLink>; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Cooper+JL%22">Cooper JL</searchLink>; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Mupo+A%22">Mupo A</searchLink>; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Grove+CS%22">Grove CS</searchLink>; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Australia.; PathWest Division of Clinical Pathology, Queen Elizabeth II Medical Centre, Nedlands, Australia.<br /><searchLink fieldCode="AU" term="%22Lynn+C%22">Lynn C</searchLink>; Leukemia and Stem Cell Biology Group, Division of Cancer Studies, Department of Haematological Medicine, King's College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Conte+N%22">Conte N</searchLink>; Sample Phenotype Ontology Team, European Bioinformatics Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Andrews+RM%22">Andrews RM</searchLink>; Institute of Translation, Innovation, Methodology, and Engagement, Cardiff University School of Medicine, Cardiff, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Pacharne+S%22">Pacharne S</searchLink>; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Tzelepis+K%22">Tzelepis K</searchLink>; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Vijayabaskar+MS%22">Vijayabaskar MS</searchLink>; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Green+P%22">Green P</searchLink>; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rad+R%22">Rad R</searchLink>; Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.; German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Arends+M%22">Arends M</searchLink>; Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wright+P%22">Wright P</searchLink>; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom; and.<br /><searchLink fieldCode="AU" term="%22Yusa+K%22">Yusa K</searchLink>; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bradley+A%22">Bradley A</searchLink>; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Varela+I%22">Varela I</searchLink>; Instituto de Biomedicina y Biotecnología de Cantabria, Santander, Spain.<br /><searchLink fieldCode="AU" term="%22Vassiliou+GS%22">Vassiliou GS</searchLink>; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom; and.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2017 Oct 26; Vol. 130 (17), pp. 1911-1922. <i>Date of Electronic Publication: </i>2017 Aug 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28835438
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/blood-2017-01-760595
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1911
    Titles:
      – TitleFull: Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dovey OM
      – PersonEntity:
          Name:
            NameFull: Cooper JL
      – PersonEntity:
          Name:
            NameFull: Mupo A
      – PersonEntity:
          Name:
            NameFull: Grove CS
      – PersonEntity:
          Name:
            NameFull: Lynn C
      – PersonEntity:
          Name:
            NameFull: Conte N
      – PersonEntity:
          Name:
            NameFull: Andrews RM
      – PersonEntity:
          Name:
            NameFull: Pacharne S
      – PersonEntity:
          Name:
            NameFull: Tzelepis K
      – PersonEntity:
          Name:
            NameFull: Vijayabaskar MS
      – PersonEntity:
          Name:
            NameFull: Green P
      – PersonEntity:
          Name:
            NameFull: Rad R
      – PersonEntity:
          Name:
            NameFull: Arends M
      – PersonEntity:
          Name:
            NameFull: Wright P
      – PersonEntity:
          Name:
            NameFull: Yusa K
      – PersonEntity:
          Name:
            NameFull: Bradley A
      – PersonEntity:
          Name:
            NameFull: Varela I
      – PersonEntity:
          Name:
            NameFull: Vassiliou GS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 10
              Text: 2017 Oct 26
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1528-0020
          Numbering:
            – Type: volume
              Value: 130
            – Type: issue
              Value: 17
          Titles:
            – TitleFull: Blood
              Type: main
ResultId 1